一二三四区视频,亚洲少妇熟女色,日本久热无码视频网,欧美国产日韩大尺度,亚洲a视频,久久少妇一区二区,日韩999无码视频,刺激久久久久久久,啊啊啊啊不要啊在线

ChemicalBook >> journal list >> Clinical and experimental obstetrics & gynecology >>article
Clinical and experimental obstetrics & gynecology

Clinical and experimental obstetrics & gynecology

IF: 0.4
Download PDF

Proof of concept study of a novel bioadhesive clindamycin phosphate 2% vaginal gel to treat bacterial vaginosis

Published:14 August 2020 DOI: 10.31083/j.ceog.2020.04.5304
A. Dupre,?H. Alur,?D. Friend

Abstract

The objective of the study was to evaluate the efficacy and safety of a novel single 2% clindamycin phosphate vaginal gel for the treatment of bacterial vaginosis (BV). The vaginal gel, a thermosetting bioadhesive formulation containing 2% clindamycin phosphate, was studied in a single center, single arm, open-label study. Patients (n = 30) were screened for BV using the four Amsel criteria (visit 1). A subset of ten women were also assessed using Nugent scores. Eligible patients were consented and provided a single dose of 2.0% clindamycin phosphate gel in a prefilled vaginal applicator (5-gram total dose). Patients returned to the clinic 7 to 14 days (visit 2) after dosing and again between 21 and 30 days (visit 3). Two subjects were excluded from cure rate calculations. Of the evaluable 28 patients, 24 (86%) were successfully treated (clinical cure) with a single dose of 2% clindamycin gel at visit 2. Of the ten patients evaluated for Nugent scoring, seven subjects were evaluable for bacteriologic cure. After a single dose of 2% clindamycin gel, four of seven (57%), and four of seven (57%) had a bacteriologic and therapeutic response, respectively. Of the 24 women who completed visit 2 and were cured based on Amsel criteria, 23 (96%) remained cured at visit 3. Of the subset of ten patients evaluated using Nugent scoring (bacteriologic evaluation), seven of nine (78%) had a score of 3 or less at visit 3. In this group, six of nine women were considered therapeutically cured (67%). There were no reports of adverse reactions, including local reactions to the vaginal gel product over the course of the study. These data support the expanded clinical evaluation of 2% clindamycin gel.

Substances (1)

Related products
Procduct Name CAS Molecular Formula Supplier Price
Clindamycin phosphate 24729-96-2 C18H34ClN2O8PS 632 suppliers $5.00-$2881.73

Similar articles

IF:3.9

A Phase 1 pharmacokinetic study of a single-dose bioadhesive clindamycin 2% gel for bacterial vaginosis.

Journal of Antimicrobial Chemotherapy Christine K Mauck,?George J Atiee,etc Published: 23 December 2022
IF:2.4

Comparison of Clindamycin Phosphate Vaginal Cream With Triple Sulfonamide Vaginal Cream in the Treatment of Bacterial Vaginosis

Sexually transmitted diseases W. Mccormack,?Jean M. Covino,etc Published: 1 October 2001
IF:96.2

A preliminary study of ritonavir, an inhibitor of HIV-1 protease, to treat HIV-1 infection.

New England Journal of Medicine M Markowitz, M Saag,etc Published: 7 December 1995
界首市| 邵阳县| 邓州市| 永城市| 航空| 右玉县| 竹山县| 勃利县| 炉霍县| 襄汾县| 天长市| 宣汉县| 昌平区| 新巴尔虎左旗| 依安县| 广元市| 大方县| 崇信县| 华蓥市| 西华县| 绥化市| 秦安县| 秦安县| 嘉祥县| 阿勒泰市| 上饶市| 花莲县| 揭阳市| 上高县| 昌平区| 平阴县| 从江县| 即墨市| 云南省| 抚松县| 名山县| 宁武县| 遵义市| 台南县| 固安县| 长春市|